...
首页> 外文期刊>Cancer letters >Valsartan protects pancreatic islets and adipose tissue from the inflammatory and metabolic consequences of a high-fat diet in mice.
【24h】

Valsartan protects pancreatic islets and adipose tissue from the inflammatory and metabolic consequences of a high-fat diet in mice.

机译:缬沙坦可保护胰岛和脂肪组织免受高脂饮食对小鼠的炎症和代谢影响。

获取原文
获取原文并翻译 | 示例
           

摘要

Obesity, hypertension, cardiovascular disease, and inflammation are closely associated with the rising incidence of diabetes mellitus. One pharmacological target that may have significant potential to lower the risk of obesity-related diseases is the angiotensin type 1 receptor (AT1R). We examined the hypothesis that the AT1R blocker valsartan reduces the metabolic consequences and inflammatory effects of a high-fat (Western) diet in mice. C57BL/6J mice were treated by oral gavage with 10 mg/kg per day of valsartan or vehicle and placed on either a standard chow or Western diet for 12 weeks. Western diet-fed mice given valsartan had improved glucose tolerance, reduced fasting blood glucose levels, and reduced serum insulin levels compared with mice fed a Western diet alone. Valsartan treatment also blocked Western diet-induced increases in serum levels of the proinflammatory cytokines interferon-gamma and monocyte chemotactic protein 1. In the pancreatic islets, valsartan enhanced mitochondrial function and prevented Western diet-induced decreases in glucose-stimulated insulin secretion. In adipose tissue, valsartan reduced Western diet-induced macrophage infiltration and expression of macrophage-derived monocyte chemotactic protein 1. In isolated adipocytes, valsartan treatment blocked or attenuated Western diet-induced changes in expression of several key inflammatory signals: interleukin 12p40, interleukin 12p35, tumor necrosis factor-alpha, interferon-gamma, adiponectin, platelet 12-lipoxygenase, collagen 6, inducible NO synthase, and AT1R. Our findings indicate that AT1R blockade with valsartan attenuated several deleterious effects of the Western diet at the systemic and local levels in islets and adipose tissue. This study suggests that AT1R blockers provide additional therapeutic benefits in the metabolic syndrome and other obesity-related disorders beyond lowering blood pressure.
机译:肥胖,高血压,心血管疾病和炎症与糖尿病发病率上升密切相关。一种可能具有显着降低肥胖相关疾病风险的药理学靶标是1型血管紧张素受体(AT1R)。我们检查了以下假设:AT1R阻断剂缬沙坦减少了小鼠高脂饮食(西方饮食)的代谢后果和炎症作用。 C57BL / 6J小鼠通过口服强饲法每天用10 mg / kg的缬沙坦或媒介物治疗,并置于标准食物或西式饮食中12周。与单独喂食西方饮食的小鼠相比,接受缬沙坦治疗的西方饮食喂养的小鼠具有改善的葡萄糖耐量,降低的空腹血糖水平和降低的血清胰岛素水平。缬沙坦治疗还阻止了西方饮食引起的促炎性细胞因子干扰素-γ和单核细胞趋化蛋白1血清水平的升高。在胰岛中,缬沙坦增强了线粒体功能并阻止了西方饮食引起的葡萄糖刺激的胰岛素分泌减少。在脂肪组织中,缬沙坦减少西方饮食诱导的巨噬细胞浸润和巨噬细胞衍生的单核细胞趋化蛋白1的表达。在分离的脂肪细胞中,缬沙坦治疗可阻断或减弱西方饮食诱导的几种关键炎症信号表达的变化:白介素12p40,白介素12p35 ,肿瘤坏死因子-α,干扰素-γ,脂联素,血小板12-脂加氧酶,胶原蛋白6,诱导型一氧化氮合酶和AT1R。我们的发现表明,缬沙坦对AT1R的阻断作用可减弱胰岛和脂肪组织在全身和局部水平上西方饮食的几种有害作用。这项研究表明,AT1R阻滞剂不仅可以降低血压,还可以在代谢综合征和其他与肥胖相关的疾病中提供其他治疗益处。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号